Centre of Excellence for Health, Immunity and Infections

Recent papers from Centre of Excellence for Health, Immunity and Infections

1. Serologic and clinical correlates of within-host SARS-CoV-2 genetic diversity in a large acute-infection cohortBMC Infectious Diseases · 2026
2. A Polygenic Score for Smoking Persistence Captures Differences in Cessation Age2026
3. Dose to cardiac substructures following contemporary radiotherapy for early breast cancer: evidence from 6,926 patientsEuropean Heart Journal Supplements · 2026
4. Chronic alanine aminotransferase elevation in people with HIV : Time trends over 22 years and genetic predispositionHIV Medicine · 2026
5. Stability of the HIV cascade of care throughout the COVID ‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)HIV Medicine · 2026
6. Factors Associated with Persistently Increased IL-6 Levels in People with HIVThe Journal of Infectious Diseases · 2026
7. Multi-country study on the impact of a revised consensus definition of late HIV diagnosis, Europe, 2022 to 2023Eurosurveillance · 2026
8. Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPONDOpen Forum Infectious Diseases · 2026
9. The Relationship Between the Preoperative Gut Microbiome and Systemic Inflammatory Response Syndrome After Cardiac Surgery: A Prospective Cohort StudyJournal of Cardiothoracic and Vascular Anesthesia · 2026
10. CD4+ cell count trends after common cancers in people with HIV: a multicohort collaborationAIDS · 2026
11. Non-Aspergillus fumigatus mould infections in lung transplant recipients: an international, multicentre, case–control studyThe Lancet Microbe · 2026
12. Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 EstimatesLiver International · 2026
13. Perioperative Antibiotic Prophylaxis in Burn Patients: Protocol for a Systematic ReviewActa Anaesthesiologica Scandinavica · 2026
14. Early antiretroviral therapy and long-term cancer risk in HIV: 9-year outcomes from the START randomized trialBMC Cancer · 2026
15. Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at AdmissionCritical Care Medicine · 2026
16. Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway AnalysisOpen Forum Infectious Diseases · 2026
17. Monitoring the HIV response for trans people in Europe and Central AsiaHIV Medicine · 2026
18. Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trialsJAMIA Open · 2026
19. An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe.2026
20. Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trialClinical Infectious Diseases · 2026